Rima Rachid

Rima Rachid, MD

Associate in Medicine

Assistant Professor, Harvard Medical School

    Contact: 617-355-6117
  • Fax: 617-730-0310

Medical Services

Specialties

  • Allergic Rhinitis
  • Allergy Immunology
  • Anaphylaxis
  • Asthma
  • Atopic Dermatitis
  • Drug Allergy
  • Eczema
  • Food Allergy
  • Immunotherapy
  • Immunodeficiency
  • Recurrent Infections

Departments

  • Allergy Immunology
  • Medicine

Languages

  • English

Programs

  • Allergy Program
  • Immunology Program
  • Primary Immunodeficiency Disorders Program
To schedule an appointment: Call 617-355-6117 or Request an Appointment

Experience and Education

Education

Undergraduate

American University of Beirut, 1991

Medical School

American University of Beirut, 1995

Internship

American University of Beirut, 1995-1996

Beirut, Lebanon

Residency

American University of Beirut, 1996-1998

Beirut, Lebanon

Residency

Boston Children's Hospital, 2002-2004

Boston, MA

Fellowship

Boston Children's Hospital, 1998-2002

Boston, MA

Certifications

  • Pediatrics, Allergy/Immunology

Publications

Publications powered by Harvard Catalyst Profiles
  1. Rachid R, Chatila TA. The role of the gut microbiota in food allergy. Curr Opin Pediatr. 2016 Dec; 28(6):748-753.
  2. MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J, Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J, Nadeau KC, Schneider LC. Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol. 2016 Sep 5.
  3. Yee CS, Rachid R. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions. Curr Allergy Asthma Rep. 2016 Apr; 16(4):25.
  4. Umetsu DT, Rachid R, Schneider LC. Oral immunotherapy and anti-IgE antibody treatment for food allergy. World Allergy Organ J. 2015; 8(1):20.
  5. Noval Rivas M, Burton OT, Wise P, Charbonnier LM, Georgiev P, Oettgen HC, Rachid R, Chatila TA. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity. 2015 Mar 17; 42(3):512-23.
  6. Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Noval Rivas M, Koleoglou KJ, Chatila TA, Schneider LC, Rachid R, Umetsu DT, Oettgen HC. Oral immunotherapy induces IgG antibodies that act through Fc?RIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol. 2014 Dec; 134(6):1310-1317.e6.
  7. Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol. 2013 Dec; 132(6):1368-74.
  8. Lieberman P, Rachid R. Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies. J Allergy Clin Immunol Pract. 2013 Nov-Dec; 1(6):704.
  9. Rachid R, Umetsu DT. Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol. 2012 Sep; 34(5):689-702.
  10. Rachid R, Bonilla FA. Reply. J Allergy Clin Immunol. 2012 Aug; 130(2):554.
  11. Show all
  12. Khoriaty E, McClain CD, Permaul P, Smith ER, Rachid R. Intraoperative anaphylaxis induced by the gelatin component of thrombin-soaked gelfoam in a pediatric patient. Ann Allergy Asthma Immunol. 2012 Mar; 108(3):209-10.
  13. Rachid R, Bonilla FA. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. J Allergy Clin Immunol. 2012 Mar; 129(3):628-34.
  14. Rachid R, Leslie D, Schneider L, Twarog F. Reply. J Allergy Clin Immunol. 2011 Oct; 128(4):905.
  15. Rachid R, Leslie D, Schneider L, Twarog F. Reply. J Allergy Clin Immunol. 2011 Jul; 128(1):251-2.
  16. Rachid R, Castells M, Cunningham-Rundles C, Bonilla FA. Association of anti-IgA antibodies with adverse reactions to ?-globulin infusion. J Allergy Clin Immunol. 2011 Jul; 128(1):228-230.e1.
  17. Rachid R, Leslie D, Schneider L, Twarog F. Hypersensitivity to systemic corticosteroids: an infrequent but potentially life-threatening condition. J Allergy Clin Immunol. 2011 Feb; 127(2):524-8.
  18. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Morra M, Curran J, Geha R. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007 Apr; 39(4):430-1.
  19. Rachid R, Castigli E, Geha RS, Bonilla FA. TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep. 2006 Sep; 6(5):357-62.
  20. Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha RS. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005 Aug; 37(8):829-34.
  21. Sasahara Y*, Rachid R*, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, Geha RS. * The first 2 authors contributed equally to the article. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell. 2002; 10(6):1269-81.
  22. Muwakkit S, Rachid R, Bazarbachi A, Araysi T, Dbaibo GS. Treatment-resistant infantile Evans syndrome. Pediatr Int. 2001 Oct; 43(5):502-4.
  23. Mikati MA, Werner S, Gatt A, Liu Z, Rahmeh AA, Rachid RA, Stafstrom CE, Holmes GL. Consequences of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor blockade during status epilepticus in the developing brain. Brain Res Dev Brain Res. 1999 Mar 12; 113(1-2):139-42.
  24. Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. p53-dependent ceramide response to genotoxic stress. J Clin Invest. 1998 Jul 15; 102(2):329-39.
  25. Romberg N, Chamberlain N, Saadoun D, Gentile M, Kinnunen T, Ng YS, Virdee M, Menard L, Cantaert T, Morbach H, Rachid R, Martinez-Pomar N, Matamoros N, Geha R, Grimbacher B, Cerutti A, Cunningham-Rundles C, Meffre E. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest. 2013 Oct; 123(10):4283-93.
  26. Romberg N, Virdee M, Chamberlain N, Oe T, Schickel JN, Perkins T, Cantaert T, Rachid R, Rosengren S, Palazzo R, Geha R, Cunningham-Rundles C, Meffre E. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. J Allergy Clin Immunol. 2015 Nov; 136(5):1315-25.
To schedule an appointment: Call 617-355-6117 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close